SPWR, BIOF, PEIX & Extended Watchlist

SunPower Corp. SPWR

SPWR made a move of over 20% yesterday, so we wanted to add it to our watchlist today. We like a good alternative energy play, especially the way a hot-trading big board in the sector can influence the performance of other related stocks. We find that traders tend to follow the natural trends in the alternative energy field, so today, in addition to SPWR, we will be focusing on a few other energy stocks that could be in for a price boost.

___

BioFuel Energy Corp. BIOF &  Pacific Ethanol, Inc. PEIX

We’ve grown accustomed to mentioning these two stocks in the same breath. These ethanol plays have brought us several rounds of gains in the past, and they tend to trend together. With SPWR running yesterday we were sure to direct our attention toward BIOF and PEIX as well, and sure enough, both finished out the day in the green.

Plug Power, Inc. PLUG

PLUG is an energy play that went on an extreme backslide yesterday, tanking to .12 from the previous day’s close at .25. While remaining very cautious, there may be a bottom-bounce opportunity with PLUG, so we are presenting it today as a potential recovery play.

___

SIDE NOTE:
For a more in-depth look at another alternative energy sector, solar power, head over and take a look at this message board which discusses a lot of different solar stocks.
___

Extended Watchlist:
ENTB, BBDA, SIPC, CERP, YTRV,

PSWS, ACGX & Extended Watchlist

PureSafe Water Systems, Inc. PSWS

PSWS earned us the top spot on Penny Stock Rumble yesterday, after appearing in our morning newsletter. We are pleased to report that we saw an enormous 369% move out of the stock from Monday’s low of .0049 to yesterday’s high of .023.

We saw resistance build up at the 200DMA of .0194  yesterday, a barrier we will have to breach to continue to see gains here. Should that occur, we would like to see that 200DMA hold as support. We have to remain vigilant at this stage of the game, and would urge extreme caution to those not yet in PSWS. This is a stock that has posted gains for nine straight days, so it stands to reason that a pullback could be in the cards for the near future.
___

Alliance Creative Group, Inc. ACGX

We are no strangers to ACGX, and each time we’ve talked about this stock in the past, it has gone on to bring us some handsome profits. We’ve noticed this play getting attention from other newsletters, so we thought we’d re-mention it as well.

Last Thursday, ACGX announced that it had shipped 50,000 displays for Wellnx Life Sciences’ raspberry ketone and green coffee bean weight management products to the world’s largest retailer.

The chart is in the middle of a serious uptrend. As you can see below, the Accum/Dist has recently skyrocketed, and we have an RSI that is barreling into the power zone. The PPS recently broke through the moving averages, volume has recently begun to pick up, and the PPO and Slow STO are both diverging and heading north after both made bullish crosses in recent months.

___

Extended Watchlist:
CLNP, PPHM, BWEN, SWHC, ECOB (Bottom Play – Coming Off 52-wk Lows),

Marijuana Stocks Blazing to New Highs in 2013

Marijuana Stocks Blazing to New Highs in 2013

On Monday, we encouraged everyone to check out one of our recent marijuana stock reports, where we highlighted no less than ten plays in the up-and-coming sector. We feel like a broken record at this point, having pounded the table on these stocks for a very long time, but we won’t quit parroting ourselves until we’re sure everyone understands: If you ever asked yourself “what is the next ‘big thing’?”, this is it. Marijuana stocks are the next big thing, and we’ve done our absolute best to show everyone we believe just that. It has become clear to most lawmakers that the advantages to ending marijuana prohibition, particularly from a fiscal standpoint, far outweigh any alleged drawbacks. The Marijuana Stock Index has risen over 900%% since October, and it’s no coincidence. Just take a look at this article explaining how the marijuana industry is gearing up for a “legislative windfall” regarding the legal status of the now mostly-illicit substance.

This week, MWIP has thus far traded in a range from .0585-.12 gaining 105% If you take into the account the low since we first mentioned MWIP (.0024), our total cumulative gains have reached a staggering 4900% as of yesterday’s high.

ERBB hit a high of .0163 yesterday, which represents move of 104% from this week’s previous low of .008.

___

PureSafe Water Systems, Inc. PSWS

PSWS has been a successful new play on our watchlist, performing very well so far this week. It first appeared on our extended watchlist on Monday, when it was trading as low as .0049. Yesterday the stock closed at the high of day at .0075, a 53% gain from Monday’s low.

This morning’s PR:

PureSafe Water Systems, Inc. (OTCQB: PSWS) Announces The Signing Of An Exclusive Worldwide Sales And Marketing Agreement And An Engineering Package Agreement

PLAINVIEW, N.Y., Feb. 13, 2013 /PRNewswire via COMTEX/ — Leslie Kessler, CEO of PureSafe Water Systems, Inc. (OTCBB: PSWS) (OTCQB: PSWS), is pleased to announce the signing of strategic agreements with Global Equipment Marketing, Inc. (“GEM”) and Engineering Technologies Group, Inc. (“ETG”) of Hopkinton, MA.
___

Peregrine Pharmaceuticals, Inc. PPHM

Those of you who have followed us for long enough, know that PPHM is an old-time favorite of ours. We’ve tracked this play for the better part of a year now, and in that span, we’ve seen it make some stellar gains.

PPHM first began appearing in our watchlist in mid-August 2012, as it ran from 2.30-3.09, after which time it pulled back to 1.76, before skyrocketing as high as 5.50.

More recently, we’ve been looking for PPHM to challenge 2.78, a recent swing high, that represents the current main area of resistance on the chart. The company released favorable test results for its pancreatic cancer treatment this morning, so be sure to check this stock out if you have not  already done so.

This morning’s PPHM headline reads:

Peregrine Pharmaceuticals Announces Results From Phase II Clinical Trial of Bavituximab in Stage IV Pancreatic Cancer

Top-Line Results Demonstrate Signs of Anti-Tumor Activity; a 28% tumor response rate as opposed to the control group which posted a rate of just 13% These statistically significant results have the stock trading up 20% pre-market, so today should get interesting for PPHM.
___

Extended Watchlist:
ADCF, BMSN, GRPN, ZNGA, IGC,